Safety profile of isocitrate dehydrogenase inhibitors in cancer therapy: a pharmacovigilance study of the FDA Adverse Event Reporting System
Year: 2024
Type: article
Study design: Observational Study
Source: Expert Opinion on Drug Safety
Authors: Yiming Fu, Ruxue Lv, Ruizhen Li, Wenjie Li, Zhaoze Guo
Institutions: Nanfang Hospital, Southern Medical University
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4405841428